Emend Injection, Powder, Lyophilized, For Solution
Product Images NDC 0006-3061

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Emend (NDC 0006-3061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Emend 01)

Chemical structure of the active ingredients in EMEND 150 mg/5 mL, showing the molecular composition and arrangement for this Merck Sharp & Dohme LLC product.*

FDA Label Image

Principal Display Panel (150 mg Vial Carton)

The image shows the packaging label for EMEND (fosaprepitant) for Injection, strength 150 mg per vial. It includes instructions for reconstitution with 5 mL of 0.9% Sodium Chloride for injection. The label highlights that the product is a sterile lyophilized powder for intravenous use only after reconstitution and dilution, and it is a single-dose vial. The labeler is Merck Sharp & Dohme LLC. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.